Filing Details

Accession Number:
0001209191-20-011784
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-21 19:15:46
Reporting Period:
2020-02-19
Accepted Time:
2020-02-21 19:15:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1340652 Chemocentryx Inc. CCXI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226064 M Susan Kanaya C/O Chemocentryx, Inc.
850 Maude Avenue
Mountain View CA 94043
Evp, Cfo And Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-19 24,200 $10.86 118,380 No 4 M Indirect Kanaya Family Trust U/A Dtd 10/17/2012
Common Stock Disposition 2020-02-19 21,000 $50.06 97,380 No 4 S Indirect Kanaya Family Trust U/A Dtd 10/17/2012
Common Stock Disposition 2020-02-19 3,200 $50.63 94,180 No 4 S Indirect Kanaya Family Trust U/A Dtd 10/17/2012
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect Kanaya Family Trust U/A Dtd 10/17/2012
No 4 S Indirect Kanaya Family Trust U/A Dtd 10/17/2012
No 4 S Indirect Kanaya Family Trust U/A Dtd 10/17/2012
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-02-19 24,200 $0.00 24,200 $10.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,000 2028-03-05 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 91,317 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $49.51 to $50.44 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  3. Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $50.51 to $50.75 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  4. As of February 19, 2020, and prior to this transaction, the exercised options were fully vested.
  5. Not applicable.